SARS-CoV-2 Antigen Rapid Qualitative Test Type A

SARS-CoV-2 Antigen Rapid Qualitative Test Type B

BNP Rapid Quantitative Test (Chemiluminescence Immunoassay)

BNP Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Brain natriuretic peptide (BNP) concentration in human plasma that contains EDTA anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of cardiac diseases.

hscTnI Rapid Quantitative Test (Fluorescence Immunoassay)

The Biotime hscTnI (highly sensitive cardiac troponin I) Rapid Quantitative Test is intended to quantify the concentration of cTnI in human serum, plasma, or whole blood on Biotime FIA Analyzers(Semi-automatic / Automatic) by fluorescent immunoassay. It is used as an aid in the detection of myocardial Infarction. -Fluorescent immunoassay -Myocardial Infarction For in vitro diagnostic use only. For professional use only.

FLI-600 FIA Immunoassay Analyzer

FLI-600 is a fluorescent immunoassay system with 6 channels that uses blood and urine to measure the quantitative concentration of targeted analyte. Its automated test process enables to carry out multiple simultaneous tests for six different samples.

CEA Rapid Quantitative Test

Carcinoembryonic antigen (CEA) is a protein normally found in very low levels in the blood of adults. The CEA blood level may be increased in certain types of cancer and non-cancerous (benign) conditions. A CEA test is most commonly used for colorectal cancer.

ASO Rapid Quantitative Test (Fluorescence Immunoassay)

The Biotime ASO Rapid Quantitative Test is intended to quantify the concentration of ASO in human serum, plasma and whole blood onBiotime FIA Analyzer by fluorescent immunoassay. The test is used as an aid detection of auxiliary diagnosis of acute rheumatic fever. -Fluorescence immunoassay -Auxiliary diagnosis of acute rheumatic fever For in vitro diagnostic use only. For professional use only.

FLI-100 FIA Analyzer

The ALL NEW FLI-100 Analyser represents an elevated standard at Biotime, in pursuing simplicity, quality assurance, and data security for healthcare organizations. Designed for quantitative in vitro assay determinations, the Biotime FLI-100 analyser was purposefully built to support immunoassay analysis for a broad range of applications – from biomarker work to infectious disease testing. The analyser’s immunofluorescence technology yields high sensitivity, reliable, and reproducible results for convenient point-of-care diagnostic testing on one device with a small footprint.

ICE-100E Incubation Chamber

The incubation chamber is an auxiliary device for Biotime’s fluorescence immunoassay analyzer. The reaction temperature and time is critical for test results. The incubation chamber provides an optimized environment as well as automatic timers for test reactions to improve the reliability of test results.

Solutions

Covid-19 Solution

SARS-CoV-2 Antigen Rapid Test

SARS-CoV-2 Antigen Rapid Qualitative Test Type A